T. Galloway

T. Galloway, Jeffrey C Liu, M. Bhayani, 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer.

J. Ridge, M. Lango, T. Galloway, 2019, Oral oncology.

p16 status, pathologic and clinical characteristics, biomolecular signature, and long‐term outcomes in head and neck squamous cell carcinomas of unknown primary

D. Flieder, R. Mehra, J. Ridge, 2014, Head & neck.

Metastatic cervical carcinoma from an unknown primary: literature review.

J. Ridge, M. Lango, T. Galloway, 2014, Ear, nose, & throat journal.

Truth or myth: Definitive chemoradiotherapy doesn't work for HPV/p16 negative oropharyngeal squamous cell carcinoma?

D. Hayes, W. Mendenhall, T. Galloway, 2017, Oral oncology.

Head and neck tumors

E. Horwitz, R. Mehra, J. Ridge, 2003 .

Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.

D. Flieder, R. Mehra, J. Ridge, 2013, Thyroid : official journal of the American Thyroid Association.

Lymph-node-positive cutaneous nonmelanoma skin cancer: A poor-prognosis disease in need of treatment intensification.

R. Mehra, J. Ridge, E. Handorf, 2017, Ear, nose, & throat journal.

Second Tumors in Pediatric Patients Treated With Radiotherapy to the Central Nervous System

T. Galloway, R. Amdur, Amy A. Smith, 2009, American journal of clinical oncology.

Rapid recurrence in head and neck cancer: Underappreciated problem with poor outcome

J. Ridge, E. Ross, M. Lango, 2020, Head & neck.

The impact of positive margin on survival in oral cavity squamous cell carcinoma.

T. Galloway, Jeffrey C Liu, Vishaal Patel, 2021, Oral oncology.

We thank Blanchard et al 1 for highlighting our recent pub- lication 2 on the impact of time to treatment initiation (TTI)

B. Egleston, J. Ridge, E. Handorf, 2016 .

Medical Communication-related Informational Need and Resource Preferences Among Family Caregivers for Head and Neck Cancer Patients

C. Parvanta, C. Fang, T. Galloway, 2015, Journal of Cancer Education.

The Role for Radiation Therapy in the Management of Sarcoma.

T. Galloway, B. Leachman, 2016, The Surgical clinics of North America.

Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis

T. Galloway, Charles T. Lee, 2022, Current Treatment Options in Oncology.

The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the head and neck cancer model

E. H. Shiguemori, V. Grégoire, A. Sanabria, 2020, Cancer Causes & Control.

Reply to P. Blanchard et al.

B. Egleston, J. Ridge, E. Handorf, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of Sentinel Lymph Node Biopsy and LVI on Merkel Cell Carcinoma Prognosis and Treatment

M. Lango, T. Galloway, J. Bauman, 2020, The Laryngoscope.

Treatment of Head and Neck Cancer-Sometimes, Less Is More.

J. Ridge, T. Galloway, 2019, JAMA otolaryngology-- head & neck surgery.

Evaluation and management of head and neck squamous cell carcinoma of unknown primary.

T. Galloway, Jeffrey M. Martin, 2015, Surgical oncology clinics of North America.

Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue.

D. Flieder, R. Mehra, J. Ridge, 2013, Oral oncology.

Impact of baseline patient‐reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation

R. Mehra, J. Ridge, M. Lango, 2016, Head & neck.

Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication

D. Hayes, B. Vincent, R. Mehra, 2020, Clinical Cancer Research.

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

J. Shah, G. Weinstein, R. Weber, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion

W. Mendenhall, T. Galloway, R. Amdur, 2005, Cancer.

Surgical excision, Mohs micrographic surgery, external‐beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta‐analysis of 58 studies with 21,000 patients

Nicholas G Zaorsky, M. Lango, T. Galloway, 2019, Cancer.

Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis.

Nicholas G Zaorsky, T. Galloway, S. Keith, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis.

Nicholas G Zaorsky, T. Galloway, E. Zhang, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of Radiographic Findings on For Prognosis Skin Cancer With Perineural Invasion

W. Mendenhall, T. Galloway, R. Amdur, 2015, American journal of clinical oncology.

Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion

W. Mendenhall, T. Galloway, R. Amdur, 2005, Cancer.

The role of radiation therapy in the management of sialorrhea: A systematic review

Nicholas G Zaorsky, T. Galloway, Nathan M. Hawkey, 2016, The Laryngoscope.

Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV‐associated oropharyngeal cancer

D. Flieder, T. Galloway, J. Bauman, 2022, Head & neck.

Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1

D. Flieder, R. Mehra, E. Golemis, 2017, Head & neck.

The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer.

R. Mehra, J. Ridge, E. Handorf, 2016, International journal of radiation oncology, biology, physics.

Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

D. Flieder, B. Egleston, R. Mehra, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129.

Christopher U. Jones, K. Ang, R. Weber, 2017, International journal of radiation oncology, biology, physics.

Early oral tongue cancer initially managed with surgery alone: Treatment of recurrence☆

R. Mehra, J. Ridge, M. Lango, 2016, World journal of otorhinolaryngology - head and neck surgery.

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition.

J. Bauman, B. Burtness, T. Galloway, 2013, The Lancet. Oncology.

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

K. Ang, R. Weber, C. Chung, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.

F. Zhu, Hong Wu, T. Galloway, 2014, Journal of the American Academy of Dermatology.

The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial

Anurag K. Singh, J. Weidhaas, C. Chung, 2017, JAMA oncology.

Head and Neck Sarcomas: A Comprehensive Cancer Center Experience

M. von Mehren, M. Tejani, J. Ridge, 2013, Cancers.

Analysis of dose at the site of second tumor formation after radiotherapy to the central nervous system.

T. Galloway, R. Amdur, D. Indelicato, 2012, International journal of radiation oncology, biology, physics.

Favorable outcomes of pediatric patients treated with radiotherapy to the central nervous system who develop radiation-induced meningiomas.

T. Galloway, R. Amdur, D. Indelicato, 2011, International journal of radiation oncology, biology, physics.

Impact of primary tumor‐specific growth rate on treatment failure for nonoropharyngeal head and neck cancers

M. Lango, T. Galloway, T. Churilla, 2019, The Laryngoscope.

Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer.

K. Devarajan, R. Mehra, J. Ridge, 2015, Oral oncology.

Time abides long enough for those who make use of it

T. Galloway, M. Fareed, 2018, Cancers of the Head & Neck.

Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.

Q. Zhang, Q. Le, A. Fortin, 2016, International journal of radiation oncology, biology, physics.

Increasing time to treatment initiation for head and neck cancer: An analysis of the National Cancer Database

D. Flieder, R. Mehra, J. Ridge, 2015, Cancer.

Unilateral neck therapy in the human papillomavirus ERA: Accepted regional spread patterns

R. Mehra, J. Ridge, M. Lango, 2013, Head & neck.

Identification and management of late dysfunction in survivors of head and neck cancer: Implementation and outcomes of an interdisciplinary quality of life (IQOL) clinic

J. Ridge, T. Galloway, Jeffrey C Liu, 2021, Head & neck.

Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria

Steven S. Chang, J. Cooper, S. Yom, 2020, Head & neck.

Revisiting unnecessary larynx irradiation with whole-neck IMRT.

W. Mendenhall, Chihray R Liu, T. Galloway, 2011, Practical radiation oncology.

Pelvic Reirradiation Utilizing Pulsed Low-dose Rate Radiation Therapy

E. Horwitz, T. Galloway, R. Price, 2020, American journal of clinical oncology.

Local Control and Toxicity of External Beam Reirradiation With a Pulsed Low-dose-rate Technique.

T. Galloway, Yanqun Dong, Tianyu Li, 2017, International journal of radiation oncology, biology, physics.

Development of a Web-Based Supportive Care Program for Patients With Head and Neck Cancer

B. Egleston, J. Ridge, S. Manne, 2020, Frontiers in Oncology.

A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma

Jing Wang, Jill Gilbert, Nabil F. Saba, 2015, Clinical Cancer Research.

A Hard Case to Swallow: Multiple Primary Cancers With Multiple Possible Answers in the Setting of Solid Organ Transplantation.

T. Galloway, R. M. Shulman, 2022, International journal of radiation oncology, biology, physics.

Examining adjuvant radiation dose in head and neck squamous cell carcinoma

J. Ridge, E. Handorf, T. Galloway, 2019, Head & neck.

HPV Association and the Increasing Incidence of Unknown Primary Head-and-Neck Squamous Cell Carcinoma : Epidemiology and Prevention

D. Flieder, R. Ferris, R. Mehra, 2014 .

Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.

Steven S. Chang, J. Cooper, S. Yom, 2022, International journal of radiation oncology, biology, physics.

Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraints.

J. Ridge, T. Galloway, Jeffrey C Liu, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Investigating the dosimetric benefits of modulated electron radiation therapy (MERT) for partial scalp patients

C. Ma, O. Chibani, T. Galloway, 2017 .

Docetaxel and gefitinib in the first-line treatment of elderly patients (≥70) with advanced non-small cell lung cancer (ANSCLC): Results of phase II trial

G. Bepler, E. Haura, T. Galloway, 2005 .

Planning target volume-to-skin proximity for head-and-neck intensity modulated radiation therapy treatment planning.

T. Galloway, I. Veltchev, R. Price, 2014, Practical radiation oncology.

A Pilot Study of a Collaborative Palliative and Oncology Care Intervention for Patients with Head and Neck Cancer.

J. Temel, B. Egleston, J. Ridge, 2021, Journal of palliative medicine.

Rapid Recurrence in Head and Neck Cancer: an Underappreciated Problem with Poor Outcome

J. Ridge, E. Ross, M. Lango, 2019, International Journal of Radiation Oncology, Biology, Physics.

Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers

T. Galloway, M. Fareed, Rizwan Ishtiaq, 2018, Current Treatment Options in Oncology.

Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation.

K. Kuchta, T. Galloway, Jeffrey C Liu, 2019, Oral oncology.

The Impact of Health Insurance Status on the Presentation, Local Management, and Outcomes of Patients With Head and Neck Cancer in the United States

B. Egleston, M. Lango, T. Galloway, 2016 .

Angiosarcoma of the Adrenal Gland Treated Using a Multimodal Approach

H. Cooper, N. Waingankar, T. Galloway, 2016, Urology case reports.

Dysplasia at the Margin? Investigating the Case for Subsequent Therapy in Squamous Cell Carcinoma of the Oral Tongue

D. Flieder, R. Mehra, J. Ridge, 2012 .

Online Exclusives

J. Ridge, M. Lango, T. Galloway, 2014, Ear, nose, & throat journal.

Head and neck surgery recommendations during the COVID-19 pandemic

J. Ridge, T. Galloway, G. Junior, 2020, The Lancet Oncology.

Second Tumors in Pediatric Patients Treated With Radiotherapy to the Central Nervous System

T. Galloway, R. Amdur, Amy A. Smith, 2009, American Journal of Clinical Oncology.

A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma

A. Jimeno, D. Raben, R. Mehra, 2015, Clinical Cancer Research.

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Christopher U. Jones, E. Sturgis, P. Harari, 2019, The Lancet.

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition.

J. Bauman, B. Burtness, T. Galloway, 2013, The Lancet. Oncology.

Low Rates of Gastrostomy Tube Dependence in Patients with T1-T2 Oropharynx Cancer Treated without Pharyngeal Constrictor Sparing

E. Horwitz, R. Mehra, J. Ridge, 2011 .